IL2 and acute myeloid leukemia: Lymphodepletion with busulfan, fludarabine and ATG followed by IL-2 activated haploidentical NK cells showed increased efficacy with delivery of CD56+ cells (p = 0.022) in high-risk AML, MDS and CML without an increase of GVHD [61].